Guillermo Arango Duque

Dr. Guillermo Arango Duque

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2014 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
GDGuillermo Arango Duque
Guillermo Arango Duque
ADAlbert Descoteaux
Albert Descoteaux
The evolution of macrophages has made them primordial for both development and immunity. Their functions range from the shaping of body plans to the ingestion and elimination of apoptotic cells and pathogens. Cytokines are small soluble proteins that confer instructions and mediate communication among immune and non-immune cells. A portfolio of cytokines is central to the role of macrophages as sentries of the innate immune system that mediate the transition from innate to adaptive immunity. In concert with other mediators, cytokines bias the fate of macrophages into a spectrum of inflammation-promoting ‘classically activated’, to anti-inflammatory or ‘alternatively activated’ macrophages. Deregulated cytokine secretion is implicated in several disease states ranging from chronic inflammation to allergy. Macrophages release cytokines via a series of beautifully orchestrated pathways that are spatiotemporally regulated. At the molecular level, these exocytic cytokine secretion pathways are coordinated by multi-protein complexes that guide cytokines from their point of synthesis to their ports of exit into the extracellular milieu. These trafficking proteins, many of which were discovered in yeast and commemorated in the 2013 Nobel Prize in Physiology or Medicine, coordinate the organelle fusion steps that are responsible for cytokine release. This review discusses the functions of cytokines secreted by macrophages, and summarizes what is known about their release mechanisms. This information will be used to delve into how selected pathogens subvert cytokine release for their own survival.

1 August 2015 in Current Opinion in Microbiology
Verified
Journal Article
Closed access
GDGuillermo Arango Duque
Guillermo Arango Duque
ADAlbert Descoteaux
Albert Descoteaux

1 September 2014 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
GDGuillermo Arango Duque
Guillermo Arango Duque
Mitsunori FukudaMitsunori Fukuda
Mitsunori Fukuda
STSalvatore J. Turco
Salvatore J. Turco
SSSimona Stäger
Simona Stäger
ADAlbert Descoteaux
Albert Descoteaux
Synaptotagmins (Syts) are type-I membrane proteins that regulate vesicle docking and fusion in processes such as exocytosis and phagocytosis. We recently discovered that Syt XI is a recycling endosome- and lysosome-associated protein that negatively regulates the secretion of TNF and IL-6. In this study, we show that Syt XI is directly degraded by the zinc metalloprotease GP63 and excluded from Leishmaniaparasitophorous vacuoles by the promastigotes surface glycolipid lipophosphoglycan. Infected macrophages were found to release TNF and IL-6 in a GP63-dependent manner. To demonstrate that cytokine release was dependent on GP63-mediated degradation of Syt XI, small interfering RNA-mediated knockdown of Syt XI before infection revealed that the effects of small interfering RNA knockdown and GP63 degradation were not cumulative. In mice, i.p. injection of GP63-expressing parasites led to an increase in TNF and IL-6 secretion and to an augmented influx of neutrophils and inflammatory monocytes to the inoculation site. Both of these cell types have been shown to be infection targets and aid in the establishment of infection. In sum, our data revealed that GP63 induces proinflammatory cytokine release and increases infiltration of inflammatory phagocytes. This study provides new insight on how Leishmania exploits the immune response to establish infection.

15 February 2013 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
GDGuillermo Arango Duque
Guillermo Arango Duque
Mitsunori FukudaMitsunori Fukuda
Mitsunori Fukuda
ADAlbert Descoteaux
Albert Descoteaux
Synaptotagmins (Syts) are a group of type I membrane proteins that regulate vesicle docking and fusion in processes such as exocytosis and phagocytosis. All Syts possess a single transmembrane domain, and two conserved tandem Ca2+-binding C2 domains. However, Syts IV and XI possess a conserved serine in their C2A domain that precludes these Syts from binding Ca2+ and phospholipids, and from mediating vesicle fusion. Given the importance of vesicular trafficking in macrophages, we investigated the role of Syt XI in cytokine secretion and phagocytosis. We demonstrated that Syt XI is expressed in murine macrophages, localized in recycling endosomes, lysosomes, and recruited to phagosomes. Syt XI had a direct effect on phagocytosis and on the secretion of TNF and IL-6. Whereas small interfering RNA–mediated knockdown of Syt XI potentiated secretion of these cytokines and particle uptake, overexpression of an Syt XI construct suppressed these processes. In addition, Syt XI knockdown led to decreased recruitment of gp91phox and lysosomal-associated membrane protein–1 to phagosomes, suggesting attenuated microbicidal activity. Remarkably, knockdown of Syt XI ensued in enhanced bacterial survival. Our data reveal a novel role for Syt XI as a regulator of cytokine secretion, particle uptake, and macrophage microbicidal activity.

29 July 2019 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
GDGuillermo Arango Duque
Guillermo Arango Duque
AJArmando Jardim
Armando Jardim
ÉGÉtienne Gagnon
Étienne Gagnon
Mitsunori FukudaMitsunori Fukuda
Mitsunori Fukuda
ADAlbert Descoteaux
Albert Descoteaux
To colonize phagocytes, Leishmania subverts microbicidal processes through components of its surface coat that include lipophosphoglycan and the GP63 metalloprotease. How these virulence glycoconjugates are shed, exit the parasitophorous vacuole (PV), and traffic within host cells is poorly understood. Here, we show that lipophosphoglycan and GP63 are released from the parasite surface following phagocytosis and redistribute to the endoplasmic reticulum (ER) of macrophages. Pharmacological disruption of the trafficking between the ER and the Golgi hindered the exit of these molecules from the PV and dampened the cleavage of host proteins by GP63. Silencing by RNA interference of the soluble N-ethylmaleimide-sensitive-factor attachment protein receptors Sec22b and syntaxin-5, which regulate ER-Golgi trafficking, identified these host proteins as components of the machinery that mediates the spreading of Leishmania effectors within host cells. Our findings unveil a mechanism whereby a vacuolar pathogen takes advantage of the host cell's secretory pathway to promote egress of virulence factors beyond the PV. Leishmania promastigotes are internalized by phagocytes into a highly modified phagosome that promotes parasite growth and differentiation into the amastigote form. To survive in the phagosome, Leishmania employs surface-bound glycoconjugates such as the GP63 metalloprotease and lipophosphoglycan to subvert the phagosome’s microbicidal potential. In particular, GP63 cleaves host cell vesicle fusion molecules that regulate phagosomal processes ranging from antigen cross-presentation to cytokine secretion. Unlike apicomplexan parasites and bacteria, Leishmania does not inject its virulence-associated glycoconjugates across the phagosome membrane. We found that post-phagocytosis, Leishmania co-opts the host cell secretory pathway to promote the egress of its virulence factors out of the phagosome. Importantly, chemical and genetic inhibition of endoplasmic reticulum (ER) to Golgi transport hindered the redistribution of GP63 and lipophosphoglycan, thereby impeding the cleavage of GP63 target Synaptotagmin XI. Notably, knockdown ER/ERGIC-resident membrane fusion regulators Sec22b and syntaxin-5 revealed that these host molecules were essential to the phagosomal egress of Leishmania virulence factors. These findings provide new insight into how Leishmania sabotages the host cell endomembrane system for its own benefit.

1 June 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
VCVisnu Chaparro
Visnu Chaparro
LLLouis-Philippe Leroux
Louis-Philippe Leroux
LMLaia Masvidal
Laia Masvidal
JLJulie Lorent
Julie Lorent
TGTyson E Graber
Tyson E Graber
MJMaritza Jaramillo
Maritza Jaramillo
The protozoan parasite Leishmania donovani (L. donovani) causes visceral leishmaniasis, a chronic infection which is fatal when untreated. Herein, we investigated whether in addition to altering transcription, L. donovani modulates host mRNA translation to establish a successful infection. Polysome-profiling revealed that one third of protein-coding mRNAs expressed in primary mouse macrophages are differentially translated upon infection with L. donovani promastigotes or amastigotes. Gene ontology analysis identified key biological processes enriched for translationally regulated mRNAs and were predicted to be either activated (e.g. chromatin remodeling and RNA metabolism) or inhibited (e.g. intracellular trafficking and antigen presentation) upon infection. Mechanistic in silico and biochemical analyses showed selective activation mTOR- and eIF4A-dependent mRNA translation, including transcripts encoding central regulators of mRNA turnover and inflammation (i.e. PABPC1, EIF2AK2, and TGF-β). L. donovani survival within macrophages was favored under mTOR inhibition but was dampened by pharmacological blockade of eIF4A. Overall, this study uncovers a vast yet selective reprogramming of the host cell translational landscape early during L. donovani infection, and suggests that some of these changes are involved in host defense mechanisms while others are part of parasite-driven survival strategies. Further in vitro and in vivo investigation will shed light on the contribution of mTOR- and eIF4A-dependent translational programs to the outcome of visceral leishmaniasis. Protozoan parasites of the genus Leishmania are the causative agents of leishmaniases, a group of diseases that range from cutaneous to potentially lethal visceral forms. Unfortunately, no efficient vaccine has been developed yet and drug resistance is rapidly increasing. Hence, the current situation reflects an urgent need for a better understanding of the molecular underpinnings of the interactions between Leishmania and its host in order to identify novel regulatory nodes for therapeutic intervention. During infectious diseases, fine-tuning the efficiency of mRNA translation into proteins allows cells to tailor their anti-microbial responses but can also be exploited by the invading pathogen. Using a global-scale translatome-based approach in macrophages, herein we report a profound perturbation in host mRNA translation during L. donovani infection. Our computational analyses reveal that subsets of host mRNAs encoding functionally related proteins share the same directionality of translational regulation, suggesting that key metabolic and microbicidal functions are hijacked by L. donovani via modulation of mRNA translation. We also show enrichment of reported mTOR- and eIF4A-sensitive mRNAs in the translationally activated dataset, including several immune-related transcripts. Finally, we report that in contrast to mTOR blockade, pharmacological inhibition of eIF4A hinders intramacrophage L. donovani survival. Thus, our study warrants further investigation on the potential of targeting eIF4A-dependent host mRNA translation to treat L. donovani infections.